A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects

• Drug: Amodiaquine (Test)
  
  Oral tablet, single dose, 1 X 300 MG
  Other Name: Camoquin
• Drug: Amodiaquine (Comparator)
  
  Oral tablet, single dose, 2 X 150 MG
  Other Name: Camoquin

• Experimental: Amodiaquine (Pfizer)
  
  Intervention: Drug: Amodiaquine (Test)
• Active Comparator: Amodiaquine tablets (Arsuamoon-Guilin China)
  
  Intervention: Drug: Amodiaquine (Comparator)

Inclusion Criteria:

• Healthy male and/or female subjects between the ages of 21 and 55 years, inclusive.
• BMI of 18 to 30 kg/m2; and a total body weight >45 kg (99 lbs).
• An informed consent document signed and dated by the subject or a legally acceptable representative.

Exclusion Criteria:

• Evidence or history of clinically significant abnormalities.
• A positive urine drug screen, history of regular alcohol consumption.